THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS

Abstract number: P-M-408

Sayilan Sen¹ H.H.S., Salcioglu¹ Z., Akici¹ F., Aydogan¹ G., Ulucakli¹ O., Yanilmaz¹ O., Aktay Ayaz¹ N., Aldemir¹ H.

¹clinics of pediatric hematology-onkology, Ministry of health Istanbul Bakirkoy women and children diseases education hospital, istanbul, Turkey

How-to-cite Sayilan Sen HHS, Salcioglu Z, Akici F, Aydogan G, Ulucakli O, Yanilmaz O, Aktay Ayaz N, Aldemir H. THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS. J Thromb Haemost 2007; 5 Supplement 2: P-M-408

Abstract

Introduction: Hematological and oncological diseases, different immune deficiency casesand chemoterapy regimens can cause neutropenia. Whatever the cause is neutropenia leads to the development of infections.

Methods: We have evalutaed 197 cases having 527 febrile neutropenia attacks during January 2003 and January 2006 retrospectively.

Results: Of the patients 243 (46.1%) were females and 284 (53.9%) were males. Origin of fever could not be found in 35% of neutropenic patients (186 attacks). In 10.6% of the patients (56 attacks) lung involvement, in 9.7% (51 attacks) gastrointestinal involvement, in 6.8% (36 attacks) blood, in 6.5% (34 attacks) severe mucositis and in 6.5% (34 attacks) urinary involvement were detected.

In 83 attacks (15.7%) there were positive hemocultures. Culture results were; Staph. Epidermidis in 40.9% (34), Gr (-) rods in 25.3% (21), Enterobacter in 14.4% (12), Klebsiella in 0.5% (4). In 303 attacks (57.5%) monotherapy with carbapenem, in 33 attacks (6.3%) combination therapy with carbapenem and aminoglycosides were given. In 191 attacks (36.2%) different antibiotic regimens were used.

Attacks according to the diseases were; 271 (51.4%) ALL, 66 (12.5%) neuroblastoma, 55 (10.4%) ANLL, 42 (8%) NHL. The duration of neutropenia was between 3 and 105 days (14.12).Growth factor was used in 330 (62%) of the attacks. Modification of the antibiotherapy was done in 254 attacks (48%). Antifungal therapy was added in 168 attacks (31.9%). Of these patients 27 (5.1%) were lost with etiologies added to febrile neutropenia.

Conclusions: We pointed out the efficiency of monotherapy and the intensification of efficiency with different modifications of monotherapy.

To cite this abstract use the following format:

Journal of Thrombosis and Haemostasis 2007; Volume 5, Supplement 2: abstract number

Session Details

Date:	01/08/2007
Time:	00:00-00:00
Session name:	XXIst ISTH Congress
Subject:
Location:	Oxford, UK
Presentation type:
Back to top